Patients with Covid 19. Covid 19
Conditions
Interventions
Intervention 1: Intervention group: Oral Deferiprone is added to drugs used to treat Covid 19 (approved by the National Committee). Intervention 2: Control group: Patients receive only the drugs used
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Covid 19 patients without needing ventilator Age between 18 to 80
Exclusion criteria
Exclusion criteria: Patients with anemia Patients with gastroenteritis Patients who had history of liver diseases Patients who had history of renal diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in disease symptoms (Fever and breathing). Timepoint: This primary outcome is measured for patients before and during 5 days after treatment initiation. Method of measurement: Fever is calculated using mercury thermometers and respiration is calculated using the number of breaths per minute. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospital stay. Timepoint: Based on the number of days a person is hospitalized. Method of measurement: Medical records.;Improvement in SPO2 to FiO2 ratio. Timepoint: Percent of SPO2. Method of measurement: Based on Oximeter pulse.;Death. Timepoint: Number of death in each group. Method of measurement: Medical Records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhaled Rahmani
Sanandaj University of Medical Sciences
Outcome results
None listed